+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Rheumatic"

Arthritis Treatment Drugs Markets in China - Product Thumbnail Image

Arthritis Treatment Drugs Markets in China

  • Report
  • July 2023
  • 238 Pages
  • China
From
From
From
From
From
From
From
From
From
From
From
From
Arthritis Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Arthritis Treatment Drugs Industry Forecasts - China Focus

  • Report
  • July 2023
  • 104 Pages
  • China
From
From
From
From
Loading Indicator

The Anti Rheumatic market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of rheumatic diseases. These diseases are caused by an abnormal immune response, which can lead to inflammation and joint pain. Anti Rheumatic drugs are used to reduce inflammation and pain, as well as to prevent further damage to the joints. These drugs can be administered orally, intravenously, or topically. Commonly used Anti Rheumatic drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic response modifiers. Some companies in the Anti Rheumatic market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more